Widespread plaque psoriasis responsive to mycophenolate mofetil.
A woman with a long history of widespread plaque psoriasis unresponsive to and/or intolerant of phototherapy, retinoids, methotrexate and cyclosporin was successfully treated with mycophenolate mofetil. Remission was maintained on doses between 1 and 1.5 g/day for 18 months without adverse effects.
Tong
D W
DW
Department of Dermatology, Prince of Wales Hospital, Randwick, New South Wales, Australia.
Walder
B K
BK
D000328:Adult; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007213:Indomethacin / Q000627:therapeutic use; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D010894:Piroxicam / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D010894:Piroxicam; D009173:Mycophenolic Acid; D011241:Prednisone; D007213:Indomethacin